楼主: chate21
1221 1

[商学院] PHARMACEUTICAL AND BIOMEDICAL PROJECT MANAGEMENT [推广有奖]

  • 4关注
  • 23粉丝

已卖:1231份资源

博士生

75%

还不是VIP/贵宾

-

威望
0
论坛币
19341 个
通用积分
20.5292
学术水平
12 点
热心指数
12 点
信用等级
6 点
经验
7701 点
帖子
321
精华
0
在线时间
231 小时
注册时间
2011-7-11
最后登录
2021-9-7

楼主
chate21 发表于 2018-5-17 10:44:39 |AI写论文

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
Scott D Babler Sean Ekins Pharmaceutical and B.pdf (1.47 MB, 需要: 100 个论坛币) 少有的医药和生物领域的项目管理教科书(398页纯正PDF版)。
具体请看前言吧。
PHARMACEUTICAL AND BIOMEDICAL PROJECT MANAGEMENT IN A CHANGING GLOBAL ENVIRONMENT

Edited by
SCOTT D. BABLER, MA, MBA, PMP, CSSBB
Integrated Project Management Company, Inc.

2010 by John Wiley & Sons, Inc. All rights reserved
ISBN 978-0-470-29341-6
FOREWORD
Within the past decade, many books have been written on the science, profession, and application of project management. Most organizations have recognized that, regardless of the level of innovation, intellectual property, resources,and capital, nothing matters without quick, reliable, and effective execution.
Additionally, today we face a new and imposing reality: the need to compete in a very turbulent and global economy — a situation that will not likely change; it is the new normal. While this condition may have been aggravated by the economic recession that began in 2008, the downturn only accelerated the inevitable. Globalization of world markets, a shift in wealth and economic power, political instability, natural resource constraints, expanded and diverse supply chains, and accelerated technological advancements are but a handful of influences that will directly or indirectly impact businesses for the foreseeable future. Our new normal requires organizations to be globally insightful, innovative, flexible, and extraordinarily responsive to new and better information that may impact business or strategy. Organizations will need to create cultures that thrive on uncertainty and rapidly changing competitive scenarios.
As stated in Philip Kotler and John A. Caslione ’ s recently published book, Chaotics: The Business of Managing and Marketing in the Age of Turbulence, “ The economic downturn is part of a continuous oscillating Age of Turbulence, where both risk and opportunity are quickly felt around the world, now inexorably linked by globalism and technology. It ’ s a world that chews up the unprepared, but rewards the prepared — those robust companies that have the ability to quickly anticipate and effectively respond to potential threats. ”
Complex, highly regulated industries with globally dispersed organizational structures will face an unprecedented challenge to synchronize efforts to elicit the greatest benefit from its talent pool and produce better, sustainable results faster than ever. Synchronization is the process and cultural tendency by which organizations endeavor to drive collaboration and knowledge - sharing among internal cross- functional groups, while maintaining functional focus,innovation, and continuous improvement. Ironically enough, high performing functional organizations often tend to misuse internal competition to motivate functional members at the expense of overall organizational performance. The sensibility of synchronization is intuitively obvious. Notwithstanding, many companies continue to operate with models and cultures that are hindered by silos that continue to measure performance and contributions within the referenced functional borders. The ability of organizations to establish and maintain functional excellence while creating even greater functional synchronization is essential if organizations expect to capitalize on their capabilities while evolving an agility to maneuver quickly and effectively.
This book, Pharmaceutical and Biomedical Project Management in a Changing Global Environment, focuses on one of the most complex industries on this planet … an industry designed to provide unparalleled benefits to mankind. It is also an industry that is fraught with extraordinary risks, regulatory controls, and fierce competition, yet offers great financial and humanitarian opportunities. This book examines the progressive role of professional project management and its impact as viewed through the eyes of several industry leaders who have personally experienced the trials and tribulations associated with prioritizing and managing portfolios designed to rapidly move from innovative research to discovery to commercialization in a complex and
shrinking world.
With diverse operating companies spread across the globe and an increasing number of mergers and acquisitions, many life sciences companies have learned to create synchronicity among a myriad of cross - functional teams whose goals are to drive innovation from the labyrinth of laboratories, alliances, suppliers, and regulators, to medical professionals and consumers across
broad and diverse markets. The coincidental evolution of professional project management has provided a methodology to convert the forces of turbulence into productive energy and measurable results.
We thank the brilliant and extraordinarily busy individuals who agreed to collaborate with Integrated Project Management Company, Inc. (IPM) team members to make this book possible. It is our hope that the experiences shared within this text either reinforce an understanding or establish a new - found perspective on the impact that process, discipline, and leadership, delivered through professional project management competency, can have on an organization ’ s ability to sustain and thrive in both good and difficult economic times.
Founder and CEO C. Richard Panico
Integrated Project Management Company, Inc

二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝


沙发
harverywu(未真实交易用户) 在职认证  发表于 2018-6-5 22:29:58
THANKS FOR SHARING. IT IS EXTREMELY VALUABLE.

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
扫码
拉您进交流群
GMT+8, 2026-2-16 07:01